A known suppression factor in the immune system increases in HIV-infected individuals on critical immune cells, reports a study in the November 2007 issue of Nature Immunology. Key targets of HIV infection, CD4+ T cells show elevated levels of the suppression factor and are associated with rapid HIV disease progression.
Bruce Walker and colleagues evaluated HIV-positive people who progressed relatively fast to disease and found significant increases in CTLA-4 expression on CD4+ T lymphocytes compared to those who did not-- so-called 'long-term non-progressors'. The team also compared CTLA-4 expression on CD4+ T cells in people before and after receiving highly active anti-retroviral therapy and found higher T cell-associated CTLA-4 in those who were off therapy. Importantly, the team found that blocking the activity of CTLA-4 improved immune function.
These results suggest that decreasing CTLA-4 expression on CD4+ T cells may provide a potential therapy to improve lymphocyte function in HIV-infected individuals.
Bruce Walker (Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA)
Abstract available online.
(C) Nature Immunology press release.
Message posted by: Trevor M. D'Souza
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking